Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Garst

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 17, 2012
Attachment styles in patients with lung cancer and their spouses: associations with patient and spouse adjustmentLaura S Porter, Francis J Keefe, Deborah Davis, et al.
Pain|July 6, 2002
Perceptions of patients' self-efficacy for managing pain and lung cancer symptoms: correspondence between patients and family caregiversLaura S Porter, Francis J Keefe, Colleen M McBride, et al.
Lung Cancer (Amsterdam, Netherlands)|September 29, 2006
Phase II study of carboplatin, irinotecan, and thalidomide combination in patients with extensive stage small-cell lung cancerRichard F Riedel, Jeffrey Crawford, Frank Dunphy, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|September 27, 2003
Distress and motivation for smoking cessation among lung cancer patients' relatives who smokeColleen M McBride, Kathryn I Pollak, Jennifer Garst, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2007
A phase II trial of carboplatin/vinorelbine with pegfilgrastim support for the treatment of patients with advanced non-small cell lung cancerRichard F Riedel, Carolyn Andrews, Jennifer Garst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: an early measure of responseRobin T Vollmer, Ramaswamy Govindan, Stephen L Graziano, et al.
The Journal of Pain|March 4, 2009
Persistent smoking after a diagnosis of lung cancer is associated with higher reported pain levelsMarcella Daniel, Francis J Keefe, Pauline Lyna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2011
Randomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: Cancer and Leukemia Group B trial 30407Ramaswamy Govindan, Jeffrey Bogart, Thomas Stinchcombe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 6, 2010
Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trialNeal Ready, Pasi A Jänne, Jeffrey Bogart, et al.
Clinical Drug Investigation|December 14, 2006
A phase I study of dose-dense topotecan given upfront to standard therapy in patients with small cell lung cancerJennifer Garst, James E Herndon, Timothy Shafman, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 17, 2012
Attachment styles in patients with lung cancer and their spouses: associations with patient and spouse adjustmentLaura S Porter, Francis J Keefe, Deborah Davis, et al.
Pain|July 6, 2002
Perceptions of patients' self-efficacy for managing pain and lung cancer symptoms: correspondence between patients and family caregiversLaura S Porter, Francis J Keefe, Colleen M McBride, et al.
Lung Cancer (Amsterdam, Netherlands)|September 29, 2006
Phase II study of carboplatin, irinotecan, and thalidomide combination in patients with extensive stage small-cell lung cancerRichard F Riedel, Jeffrey Crawford, Frank Dunphy, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|September 27, 2003
Distress and motivation for smoking cessation among lung cancer patients' relatives who smokeColleen M McBride, Kathryn I Pollak, Jennifer Garst, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2007
A phase II trial of carboplatin/vinorelbine with pegfilgrastim support for the treatment of patients with advanced non-small cell lung cancerRichard F Riedel, Carolyn Andrews, Jennifer Garst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: an early measure of responseRobin T Vollmer, Ramaswamy Govindan, Stephen L Graziano, et al.
The Journal of Pain|March 4, 2009
Persistent smoking after a diagnosis of lung cancer is associated with higher reported pain levelsMarcella Daniel, Francis J Keefe, Pauline Lyna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2011
Randomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: Cancer and Leukemia Group B trial 30407Ramaswamy Govindan, Jeffrey Bogart, Thomas Stinchcombe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 6, 2010
Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trialNeal Ready, Pasi A Jänne, Jeffrey Bogart, et al.
Clinical Drug Investigation|December 14, 2006
A phase I study of dose-dense topotecan given upfront to standard therapy in patients with small cell lung cancerJennifer Garst, James E Herndon, Timothy Shafman, et al.
Pageof 4